These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16882750)

  • 21. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
    Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
    Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
    Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the risk of metabolic disorders increase among women with polycystic ovary morphology? A population-based study.
    Bahri Khomami M; Ramezani Tehrani F; Hashemi S; Mohammadi N; Rashidi H; Azizi F
    Hum Reprod; 2016 Jun; 31(6):1339-46. PubMed ID: 27076500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents.
    Villarroel C; López P; Merino PM; Iñiguez G; Sir-Petermann T; Codner E
    Gynecol Endocrinol; 2015; 31(8):625-9. PubMed ID: 26190534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.
    Carmina E; Orio F; Palomba S; Longo RA; Lombardi G; Lobo RA
    Fertil Steril; 2005 Aug; 84(2):413-9. PubMed ID: 16084883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus.
    Miyoshi A; Nagai S; Takeda M; Kondo T; Nomoto H; Kameda H; Hirai A; Cho K; Kimachi K; Shimizu C; Atsumi T; Miyoshi H
    J Diabetes Investig; 2013 May; 4(3):326-9. PubMed ID: 24843673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty.
    Franceschi R; Gaudino R; Marcolongo A; Gallo MC; Rossi L; Antoniazzi F; Tatò L
    Fertil Steril; 2010 Mar; 93(4):1185-91. PubMed ID: 19135667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.
    Rosenfield RL
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):412-9. PubMed ID: 25840648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries.
    Elting MW; Kwee J; Schats R; Rekers-Mombarg LT; Schoemaker J
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1589-95. PubMed ID: 11297588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 20-year follow-up of young women with polycystic ovary syndrome.
    Carmina E; Campagna AM; Lobo RA
    Obstet Gynecol; 2012 Feb; 119(2 Pt 1):263-9. PubMed ID: 22270277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
    Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
    Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
    Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Diagnostic Criteria of Polycystic Ovarian Morphology for Adolescents: Impact on Prevalence and Hormonal Profile.
    Merino PM; Villarroel C; Jesam C; López P; Codner E
    Horm Res Paediatr; 2017; 88(6):401-407. PubMed ID: 29049986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions].
    Merino P; Schulin-Zeuthen C; Codner E
    Rev Med Chil; 2009 Aug; 137(8):1071-80. PubMed ID: 19915773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraindividual right-left comparison of sonographic features in polycystic ovary syndrome (PCOS) diagnosis.
    Köninger A; Koch L; Edimiris P; Nießen S; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():124-9. PubMed ID: 25150949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do hyperandrogenic women with normal menses have polycystic ovary syndrome?
    Carmina E; Lobo RA
    Fertil Steril; 1999 Feb; 71(2):319-22. PubMed ID: 9988405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.